Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Breast Cancer

  Free Subscription


17.07.2017

2 Ann Surg
1 Ann Surg Oncol
1 Br J Cancer
1 Breast Cancer
18 Breast Cancer Res Treat
3 Breast J
1 Cancer Chemother Pharmacol
1 Cancer Epidemiol Biomarkers Prev
1 Cancer Res
2 Clin Breast Cancer
1 Exp Cell Res
1 Genes Chromosomes Cancer
4 Int J Radiat Oncol Biol Phys
3 J Biol Chem
3 J Clin Oncol
2 J Surg Oncol
1 N Engl J Med
1 NPJ Breast Cancer
1 Oncogene
2 PLoS One
1 Radiology


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Ann Surg

  1. SCHAAPVELD M, Wesseling J
    Response: DCIS and Breast Cancer: Challenging the Paradigm (Authors Victoria Sopik and Steven A. Narod)".
    Ann Surg. 2017 Jul 10. doi: 10.1097/SLA.0000000000002418.
    PubMed     Text format    

  2. SOPIK V, Narod SA
    DCIS and Breast Cancer: Challenging the Paradigm.
    Ann Surg. 2017 Jul 10. doi: 10.1097/SLA.0000000000002417.
    PubMed     Text format    


    Ann Surg Oncol

  3. MCCARTAN DP, Zabor EC, Morrow M, Van Zee KJ, et al
    Oncologic Outcomes After Treatment for MRI Occult Breast Cancer (pT0N+).
    Ann Surg Oncol. 2017 Jul 12. doi: 10.1245/s10434-017-5965.
    PubMed     Text format     Abstract available


    Br J Cancer

  4. JIANG L, Luan Y, Miao X, Sun C, et al
    Platelet releasate promotes breast cancer growth and angiogenesis via VEGF-integrin cooperative signalling.
    Br J Cancer. 2017 Jul 11. doi: 10.1038/bjc.2017.
    PubMed     Text format     Abstract available


    Breast Cancer

  5. ISHIKAWA T, Kaise H, Yamada K, Hosonaga M, et al
    Erratum to: Objection to postoperative radiation therapy in breast cancer with one to three lymph nodes involvements.
    Breast Cancer. 2017 Jul 7. doi: 10.1007/s12282-017-0792.
    PubMed     Text format    


    Breast Cancer Res Treat

  6. TROGDON JG, Ekwueme DU, Poehler D, Thomas CC, et al
    Medical costs of treating breast cancer among younger medicaid beneficiaries by stage at diagnosis.
    Breast Cancer Res Treat. 2017 Jul 12. doi: 10.1007/s10549-017-4386.
    PubMed     Text format     Abstract available

  7. VOGL SE
    Adjuvant ovarian suppression for resected breast cancer: 2017 critical assessment.
    Breast Cancer Res Treat. 2017 Jul 10. doi: 10.1007/s10549-017-4379.
    PubMed     Text format     Abstract available

  8. HILLIARD C
    Letter to the editor: In response to "influence of clinical, societal, and treatment variables on racial difference in ER-/PR- breast cancer survival" by Roseland ME, Schwartz K, Ruterbusch JJ, Lamerato L, Krajenta R, Booza J, Simon MS.
    Breast Cancer Res Treat. 2017 Jul 10. doi: 10.1007/s10549-017-4360.
    PubMed     Text format    

  9. KATZ SJ, Hawley ST, Bondarenko I, Jagsi R, et al
    Oncologists' influence on receipt of adjuvant chemotherapy: does it matter whom you see for treatment of curable breast cancer?
    Breast Cancer Res Treat. 2017 Jul 8. doi: 10.1007/s10549-017-4377.
    PubMed     Text format     Abstract available

  10. PARISE CA, Caggiano V
    Risk of mortality of node-negative, ER/PR/HER2 breast cancer subtypes in T1, T2, and T3 tumors.
    Breast Cancer Res Treat. 2017 Jul 8. doi: 10.1007/s10549-017-4383.
    PubMed     Text format     Abstract available

  11. LEYRER CM, Berriochoa CA, Agrawal S, Donaldson A, et al
    Predictive factors on outcomes in metaplastic breast cancer.
    Breast Cancer Res Treat. 2017 Jul 8. doi: 10.1007/s10549-017-4367.
    PubMed     Text format     Abstract available

  12. POUWELS XGLV, Ramaekers BLT, Joore MA
    Reviewing the quality, health benefit and value for money of chemotherapy and targeted therapy for metastatic breast cancer.
    Breast Cancer Res Treat. 2017 Jul 8. doi: 10.1007/s10549-017-4374.
    PubMed     Text format     Abstract available

  13. MU Z, Wang C, Ye Z, Rossi G, et al
    Prognostic values of cancer associated macrophage-like cells (CAML) enumeration in metastatic breast cancer.
    Breast Cancer Res Treat. 2017 Jul 7. doi: 10.1007/s10549-017-4372.
    PubMed     Text format     Abstract available

  14. MARTINEZ ME, Gomez SL, Tao L, Cress R, et al
    Contribution of clinical and socioeconomic factors to differences in breast cancer subtype and mortality between Hispanic and non-Hispanic white women.
    Breast Cancer Res Treat. 2017 Jul 11. doi: 10.1007/s10549-017-4389.
    PubMed     Text format     Abstract available

  15. HEGDE JV, Wang X, Attai DJ, DiNome ML, et al
    Predictors associated with MRI surveillance screening in women with a personal history of unilateral breast cancer but without a genetic predisposition for future contralateral breast cancer.
    Breast Cancer Res Treat. 2017 Jul 12. doi: 10.1007/s10549-017-4392.
    PubMed     Text format     Abstract available

  16. CHIHARA Y, Shimoda M, Hori A, Ohara A, et al
    A small-molecule inhibitor of SMAD3 attenuates resistance to anti-HER2 drugs in HER2-positive breast cancer cells.
    Breast Cancer Res Treat. 2017 Jul 12. doi: 10.1007/s10549-017-4382.
    PubMed     Text format     Abstract available

  17. YU AF, Mukku RB, Verma S, Liu JE, et al
    Cardiac safety of non-anthracycline trastuzumab-based therapy for HER2-positive breast cancer.
    Breast Cancer Res Treat. 2017 Jul 14. doi: 10.1007/s10549-017-4362.
    PubMed     Text format     Abstract available

  18. VAN DYK K, Hunter AM, Ercoli L, Petersen L, et al
    Evaluating cognitive complaints in breast cancer survivors with the FACT-Cog and quantitative electroencephalography.
    Breast Cancer Res Treat. 2017 Jul 13. doi: 10.1007/s10549-017-4390.
    PubMed     Text format     Abstract available

  19. YAO C, Bernstein LJ, Rich JB
    Executive functioning impairment in women treated with chemotherapy for breast cancer: a systematic review.
    Breast Cancer Res Treat. 2017 Jul 13. doi: 10.1007/s10549-017-4376.
    PubMed     Text format     Abstract available

  20. NJOROGE SW, Burgess KR, Cobleigh MA, Alnajar HH, et al
    Hereditary diffuse gastric cancer and lynch syndromes in a BRCA1/2 negative breast cancer patient.
    Breast Cancer Res Treat. 2017 Jul 12. doi: 10.1007/s10549-017-4393.
    PubMed     Text format     Abstract available

  21. RICE MS, Tworoger SS, Hankinson SE, Tamimi RM, et al
    Breast cancer risk prediction: an update to the Rosner-Colditz breast cancer incidence model.
    Breast Cancer Res Treat. 2017 Jul 12. doi: 10.1007/s10549-017-4391.
    PubMed     Text format     Abstract available

  22. KIISKI JI, Tervasmaki A, Pelttari LM, Khan S, et al
    FANCM mutation c.5791C>T is a risk factor for triple-negative breast cancer in the Finnish population.
    Breast Cancer Res Treat. 2017 Jul 12. doi: 10.1007/s10549-017-4388.
    PubMed     Text format     Abstract available

  23. TURASHVILI G, Chou JF, Brogi E, Morrow M, et al
    21-Gene recurrence score and locoregional recurrence in lymph node-negative, estrogen receptor-positive breast cancer.
    Breast Cancer Res Treat. 2017 Jul 12. doi: 10.1007/s10549-017-4381.
    PubMed     Text format     Abstract available


    Breast J

  24. ALABDULKAREEM H, Pinchinat T, Khan S, Landers A, et al
    The impact of molecular subtype on breast cancer recurrence in young women treated with contemporary adjuvant therapy.
    Breast J. 2017 Jul 14. doi: 10.1111/tbj.12853.
    PubMed     Text format     Abstract available

  25. LIU S, Khalkhali I
    Probably Benign Findings: Probably the Emperor with No Clothes.
    Breast J. 2017;23:8-9.
    PubMed     Text format    

  26. DE LARA S, Parris TZ, Werner Ronnerman E, Helou K, et al
    GATA3 as a putative marker of breast cancer metastasis-A retrospective immunohistochemical study.
    Breast J. 2017 Jul 13. doi: 10.1111/tbj.12863.
    PubMed     Text format     Abstract available


    Cancer Chemother Pharmacol

  27. PANIS C, Binato R, Correa S, Victorino VJ, et al
    Short infusion of paclitaxel imbalances plasmatic lipid metabolism and correlates with cardiac markers of acute damage in patients with breast cancer.
    Cancer Chemother Pharmacol. 2017 Jul 8. doi: 10.1007/s00280-017-3384.
    PubMed     Text format     Abstract available


    Cancer Epidemiol Biomarkers Prev

  28. EDWARDS BL, Atkins KA, Stukenborg GJ, Novicoff WM, et al
    The Association of Mammographic Density and Molecular Breast Cancer Subtype.
    Cancer Epidemiol Biomarkers Prev. 2017 Jul 11. pii: cebp.0881.2016.
    PubMed     Text format     Abstract available


    Cancer Res

  29. SOSSEY-ALAOUI K, Pluskota E, Bialkowska K, Szpak D, et al
    Kindlin-2 regulates the growth of breast cancer tumors by activating CSF-1-mediated macrophage infiltration.
    Cancer Res. 2017 Jul 7. pii: canres.2337.2016.
    PubMed     Text format     Abstract available


    Clin Breast Cancer

  30. CHOI SH, Kim JW, Choi J, Sohn J, et al
    Locoregional Treatment of the Primary Tumor in Patients With De Novo Stage IV Breast Cancer: A Radiation Oncologist's Perspective.
    Clin Breast Cancer. 2017 Jun 17. pii: S1526-8209(17)30306.
    PubMed     Text format     Abstract available

  31. PARK S, Lee JE, Yu J, Paik HJ, et al
    Risk Factors Affecting Breast Cancer-related Lymphedema: Serial Body Weight Change During Neoadjuvant Anthracycline Plus Cyclophosphamide Followed by Taxane.
    Clin Breast Cancer. 2017 Jun 21. pii: S1526-8209(16)30518.
    PubMed     Text format     Abstract available


    Exp Cell Res

  32. SMUCZEK B, Santos ES, Siqueira AS, Pinheiro JJV, et al
    The laminin-derived peptide C16 regulates GPNMB expression and function in breast cancer.
    Exp Cell Res. 2017 Jul 5. pii: S0014-4827(17)30359.
    PubMed     Text format     Abstract available


    Genes Chromosomes Cancer

  33. BUBIEN V, Bonnet F, Dupiot-Chiron J, Barouk-Simonet E, et al
    Combined tumor genomic profiling and exome sequencing in a breast cancer family implicates ATM in tumorigenesis: a proof of principle study.
    Genes Chromosomes Cancer. 2017 Jul 10. doi: 10.1002/gcc.22482.
    PubMed     Text format     Abstract available


    Int J Radiat Oncol Biol Phys

  34. MISHRA MV, Aggarwal S, Bentzen SM, Knight N, et al
    Establishing Evidence-Based Indications for Proton Therapy: An Overview of Current Clinical Trials.
    Int J Radiat Oncol Biol Phys. 2017;97:228-235.
    PubMed     Text format     Abstract available

  35. GOROVETS D, Ayala-Peacock D, Tybor DJ, Rava P, et al
    Multi-institutional Nomogram Predicting Survival Free From Salvage Whole Brain Radiation After Radiosurgery in Patients With Brain Metastases.
    Int J Radiat Oncol Biol Phys. 2017;97:246-253.
    PubMed     Text format     Abstract available

  36. ZAGAR TM, Kaidar-Person O, Tang X, Jones EE, et al
    Utility of Deep Inspiration Breath Hold for Left-Sided Breast Radiation Therapy in Preventing Early Cardiac Perfusion Defects: A Prospective Study.
    Int J Radiat Oncol Biol Phys. 2017;97:903-909.
    PubMed     Text format     Abstract available

  37. REDDY JP, Lei X, Huang SC, Nicklaus KM, et al
    Quantitative Assessment of Breast Cosmetic Outcome After Whole-Breast Irradiation.
    Int J Radiat Oncol Biol Phys. 2017;97:894-902.
    PubMed     Text format     Abstract available


    J Biol Chem

  38. MERCADO-MATOS J, Clark JL, Piper AJ, Janusis J, et al
    Differential involvement of the microtubule cytoskeleton in insulin receptor substrate 1 (IRS-1) and IRS-2 signaling to AKT determines the response to microtubule disruption in breast carcinoma cells.
    J Biol Chem. 2017;292:7806-7816.
    PubMed     Text format     Abstract available

  39. CHEN J, De Raeymaecker J, Hovgaard JB, Smaardijk S, et al
    Structure/activity relationship of thapsigargin inhibition on the purified Golgi/secretory pathway Ca2+/Mn2+-transport ATPase (SPCA1a).
    J Biol Chem. 2017;292:6938-6951.
    PubMed     Text format     Abstract available

  40. LO PK, Zhang Y, Yao Y, Wolfson B, et al
    Tumor-associated myoepithelial cells promote the invasive progression of ductal carcinoma in situ through activation of TGFbeta signaling.
    J Biol Chem. 2017;292:11466-11484.
    PubMed     Text format     Abstract available


    J Clin Oncol

  41. KROP I, Ismaila N, Andre F, Bast RC, et al
    Use of Biomarkers to Guide Decisions on Adjuvant Systemic Therapy for Women With Early-Stage Invasive Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline Focused Update.
    J Clin Oncol. 2017 Jul 10:JCO2017740472. doi: 10.1200/JCO.2017.74.0472.
    PubMed     Text format     Abstract available

  42. WALLNER LP, Li Y, Furgal AKC, Friese CR, et al
    Patient Preferences for Primary Care Provider Roles in Breast Cancer Survivorship Care.
    J Clin Oncol. 2017 Jul 12:JCO2017731307. doi: 10.1200/JCO.2017.73.1307.
    PubMed     Text format     Abstract available

  43. FOURNIER A, Mesrine S, Gelot A, Fagherazzi G, et al
    Use of Bisphosphonates and Risk of Breast Cancer in a French Cohort of Postmenopausal Women.
    J Clin Oncol. 2017 Jul 14:JCO2016714337. doi: 10.1200/JCO.2016.71.4337.
    PubMed     Text format     Abstract available


    J Surg Oncol

  44. WEVERS MR, Aaronson NK, Bleiker EMA, Hahn DEE, et al
    Rapid genetic counseling and testing in newly diagnosed breast cancer: Patients' and health professionals' attitudes, experiences, and evaluation of effects on treatment decision making.
    J Surg Oncol. 2017 Jul 13. doi: 10.1002/jso.24763.
    PubMed     Text format     Abstract available

  45. UNKART JT, Hosseini A, Wallace AM
    Tc-99m tilmanocept versus Tc-99m sulfur colloid in breast cancer sentinel lymph node identification: Results from a randomized, blinded clinical trial.
    J Surg Oncol. 2017 Jul 10. doi: 10.1002/jso.24735.
    PubMed     Text format     Abstract available


    N Engl J Med


  46. Adjuvant Pertuzumab and Trastuzumab in Early HER2-Positive Breast Cancer.
    N Engl J Med. 2017 Jul 12. doi: 10.1056/NEJMx170011.
    PubMed     Text format    


    NPJ Breast Cancer

  47. PATTERSON DG, Roberts JT, King VM, Houserova D, et al
    Human snoRNA-93 is processed into a microRNA-like RNA that promotes breast cancer cell invasion.
    NPJ Breast Cancer. 2017;3:25.
    PubMed     Text format     Abstract available


    Oncogene

  48. FETTIG LM, McGinn O, Finlay-Schultz J, LaBarbera DV, et al
    Cross talk between progesterone receptors and retinoic acid receptors in regulation of cytokeratin 5-positive breast cancer cells.
    Oncogene. 2017 Jul 10. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available


    PLoS One

  49. CAO H, Li C, Qi W, Meng X, et al
    Synthesis, cytotoxicity and antitumour mechanism investigations of polyoxometalate doped silica nanospheres on breast cancer MCF-7 cells.
    PLoS One. 2017;12:e0181018.
    PubMed     Text format     Abstract available

  50. BALHOUSE BN, Patterson L, Schmelz EM, Slade DJ, et al
    N-(3-oxododecanoyl)-L-homoserine lactone interactions in the breast tumor microenvironment: Implications for breast cancer viability and proliferation in vitro.
    PLoS One. 2017;12:e0180372.
    PubMed     Text format     Abstract available


    Radiology

  51. WU J, Li B, Sun X, Cao G, et al
    Heterogeneous Enhancement Patterns of Tumor-adjacent Parenchyma at MR Imaging Are Associated with Dysregulated Signaling Pathways and Poor Survival in Breast Cancer.
    Radiology. 2017 Jul 14:162823. doi: 10.1148/radiol.2017162823.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Breast Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: